Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 07:59:09 +0200Wed, 12 Jun 2024 09:56:00 +0200Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 37, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/solirisHuman medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 37, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/solirisWed, 12 Jun 2024 09:56:00 +0200Human medicineSoliris : EPAR - Medicine overviewhttps://www.ema.europa.eu/system/files/documents/overview/h-791-summary_en.pdfSoliris : EPAR - Medicine overviewhttps://www.ema.europa.eu/system/files/documents/overview/h-791-summary_en.pdfTue, 08 Aug 2023 17:45:00 +0200Human medicine